Detalhe da pesquisa
1.
Author Correction: FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes.
Nature
; 585(7826): E20, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32895534
2.
FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes.
Nature
; 571(7765): 408-412, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243370
3.
Quantification and molecular correlates of tertiary lymphoid structures in primary prostate cancer.
Prostate
; 84(8): 709-716, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38544351
4.
F-SHARP: a Phase I/II trial of focal salvage high-dose-rate brachytherapy for Radiorecurrent prostate cancer.
BJU Int
; 133(2): 188-196, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37562825
5.
A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.
Cancer
; 129(14): 2169-2178, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37060201
6.
Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial.
J Urol
; 209(2): 354-363, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36621991
7.
Genomic biomarkers to guide precision radiotherapy in prostate cancer.
Prostate
; 82 Suppl 1: S73-S85, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657158
8.
Does Perioperative Testosterone Predict Post-Prostatectomy Genomic Risk Score?
J Urol
; 207(6): 1214-1221, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35050721
9.
Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant Chemotherapy.
J Urol
; 207(3): 541-550, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34643090
10.
Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted Biopsy.
J Urol
; 205(5): 1344-1351, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33356482
11.
Identifying and treating ROBO1-ve /DOCK1+ve prostate cancer: An aggressive cancer subtype prevalent in African American patients.
Prostate
; 80(13): 1045-1057, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32687658
12.
Genomic and clinical characterization of stromal infiltration markers in prostate cancer.
Cancer
; 126(7): 1407-1412, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31905251
13.
A Genomic Classifier for Predicting Clinically Aggressive Luminal Bladder Tumors with Higher Rates of Pathological Up Staging.
J Urol
; 204(2): 239-246, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32074006
14.
Development of a predictive model for stromal content in prostate cancer samples to improve signature performance.
J Pathol
; 249(4): 411-424, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31206668
15.
Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer.
BMC Genomics
; 20(1): 146, 2019 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30777011
16.
Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.
Int J Cancer
; 145(12): 3453-3461, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31125117
17.
A four-gene transcript score to predict metastatic-lethal progression in men treated for localized prostate cancer: Development and validation studies.
Prostate
; 79(14): 1589-1596, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31376183
18.
Radiomics Features Measured with Multiparametric Magnetic Resonance Imaging Predict Prostate Cancer Aggressiveness.
J Urol
; 202(3): 498-505, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30958743
19.
African American Specific Gene Panel Predictive of Poor Prostate Cancer Outcome.
J Urol
; 202(2): 247-255, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31107158
20.
Correlation between MRI phenotypes and a genomic classifier of prostate cancer: preliminary findings.
Eur Radiol
; 29(9): 4861-4870, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30847589